StockData

Cartesian Therapeutics, Inc. (RNAC) stock

RNACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$6.08−0.27 (-4.25%)

Close on Nov 16, 2026Market cap $183.95MP/E –Yield –

Cartesian Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Cartesian Therapeutics's EV/EBITDA was 3.2× on Apr 28, 2023.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2023Apr 28, 20233.2×+2.2
2022Dec 30, 20221.0×–

More Cartesian Therapeutics figures

See a number that looks wrong?